1-500 | 501-1000 | 1001-1112
     Part,  Chapter, Paragraph

   1    -,     1            |                 2004 and to 27 countries in 2007, but also previously-identified
   2    I,     2.  2        |                  report by Rudiger Leidner (2007) entitled “The European
   3    I,     2.  4        |               capita in EUGLOREH Countries, 2007.~ ~GDP is defined as the
   4    I,     2.  5        |                      During the period 2006-2007 6.5 million new jobs have
   5    I,     2.  7        |                    almost 5 billion (UNFPA, 2007). In most countries, the
   6    I,     2.  7        |               healthcare services (Marrone, 2007; Arcury et al, 2005).~ ~
   7    I,     2.  9        |                   and the spring drought of 2007. Since extreme events are
   8    I,     2. 10.  2    |                 NIOSH, 2006; Schulte et al, 2007; Nel et al, 2006; Medina
   9    I,     2. 10.  2    |                     al, 2006; Medina et al, 2007).~ ~The nanoparticles categories
  10    I,     2. 10.  2    |                   al, 2006); (Medina et al, 2007).~ ~- Carbon nanoparticles:
  11    I,     2. 10.  2    |                  reported so far (September 2007) 4. In the US, the Woodrow
  12    I,     2. 10.  4(8) |             Practisise. Council of Europe - 2007~
  13    I,     2. 10.  4(9) |                    of Healthh – 16 February 2007~
  14    I,     2. 10.  4(12)|                    of Health16 Febrauary 2007~
  15    I,     2. 10.  4(14)|                    European Commission, May 2007.~
  16    I,     2. 10.  4(19)|                     of health16 February 2007~
  17    I,     2. 10.  4(21)|                   P- SP-PH- SAFE), 19 March 2007~
  18    I,     2. 10.  4(22)|                     of Health16 February 2007~
  19    I,     2. 11        |                      ILO, Geneva~Marrone S (2007): Understanding barriers
  20    I,     2. 11        |                   Int J Circumpolar Health. 2007 Jun;66(3):188-98.~Medina
  21    I,     2. 11        |                   188-98.~Medina c. et al. (2007): Nanoparticles: pharmacological
  22    I,     2. 11        |                        Schulte P.A. et al. (2007): Ethical and Scientific
  23    I,     2. 11        |                    Population Fund (UNFPA) (2007): State of the world population
  24    I,     2. 11        |                     of the world population 2007. Available at: htt ~ ~
  25   II,     4.  1        |                    et al, 1997; Kung et al, 2007)4 and the Japanese data
  26   II,     4.  1        |                  States (Robine and Jagger, 2007). Several services of the
  27   II,     4.  3        |                      H., D. Hoyert, et al. (2007): Deaths: Preliminary Data
  28   II,     4.  3        |                Robine, J.-M. and C. Jagger (2007): Healthy life expectancy
  29   II,     4.  3        |                Robine, J.-M. and C. Jagger (2007): Strategic Plan of the
  30   II,     4.  3        |                     on Health Expectancies, 2007-2010. Montpellier, Inserm~ ~
  31   II,     5.  1.  1    |                    of stomach cancer (WCRF, 2007).~ ~Colorectal cancer: the
  32   II,     5.  1.  1    |                  against this cancer (WCRF, 2007). Cancer control priority
  33   II,     5.  1.  1    |            diagnosed in premenopause (WCRF, 2007).~ ~Cervical cancer: the
  34   II,     5.  2.  2    |                  reported: EUROSTAT (htt u, 2007) for mortality data; WHO-HFA
  35   II,     5.  2.  2    |                    WHO-HFA database (htt b, 2007), specific projects such
  36   II,     5.  2.  2    |                 disease (WHO MONICA) (ht /, 2007) and population-based registers
  37   II,     5.  2.  2    |                    Surveillance Set - (h p, 2007) IHD data available from
  38   II,     5.  2.  2    |                      Muller-Nordhorn et al, 2007; Muller-Nordhorn et al,
  39   II,     5.  2.  2    |                     mortality rates (htt u, 2007).~IHD mortality was defined
  40   II,     5.  2.  2    |              diagnoses from WHO-HFA (htt b, 2007) were used to calculate
  41   II,     5.  2.  2    |                    Surveillance Set - (h p, 2007) EUROSTAT data were analyzed
  42   II,     5.  2.  2    |                     mortality rates (htt u, 2007). Stroke mortality was defined
  43   II,     5.  2.  2    |              diagnoses from WHO-HFA (htt b, 2007) and EUROSTAT (htt u, 2007)
  44   II,     5.  2.  2    |                  2007) and EUROSTAT (htt u, 2007) were used for stroke; these
  45   II,     5.  2.  2    |                  WHO MONICA Project (htt /, 2007) are reported for the age
  46   II,     5.  2.  2    |                  WHO-MONICA Project (htt /, 2007) was based on clinical findings (
  47   II,     5.  2.  2    |                    WHO HFA database (htt b, 2007). The risk factors identified
  48   II,     5.  2.  3    |                 last year available (htt b, 2007). Unfortunately these data
  49   II,     5.  2.  3    |                 last year available (htt b, 2007). Unfortunately, these data
  50   II,     5.  2.  4    |                surveys. Table 5.2.7 (htt b, 2007) provides the most recent
  51   II,     5.  2.  4    |                    Congress held in Vienna (2007). The EUROASPIRE surveys
  52   II,     5.  2.  5    |                     al, 2006; Hozawa et al, 2007; Daviglus et al, 2007).
  53   II,     5.  2.  5    |                   al, 2007; Daviglus et al, 2007). Low risk individuals live
  54   II,     5.  2.  5    |                   al, 2004, Graham I et al, 2007)~Within this context, blood
  55   II,     5.  2.  5    |              officially launched on 12 June 2007 before the European Parliament
  56   II,     5.  2.  6    |             epidemiological methods (htt p, 2007)~IHD is a complex disease
  57   II,     5.  2.  6    |                   Food and Nutrition Policy 2007-2012 (WHO, 2007) establishes
  58   II,     5.  2.  6    |            Nutrition Policy 2007-2012 (WHO, 2007) establishes health, nutrition,
  59   II,     5.  2.  6    |                   studies (Lewington et al, 2007). From a mechanistic point
  60   II,     5.  2.  6    |           established CVD) (Graham I et al, 2007).~ ~Focus Box References (
  61   II,     5.  2.  6    |             Qizilbash N, Peto R, Collins R (2007): Prospective Studies Collaboration:
  62   II,     5.  2.  7    |                  Sharrett AR, Chambless LE (2007): Absolute and Attributable
  63   II,     5.  2.  7    |                 Regional Office for Europe (2007): The Second WHO European
  64   II,     5.  2.  7    |                   Food and Nutrition Policy 2007-2012 [http://www.euro.who.
  65   II,     5.  2.  7    |                  pdf] (accessed on 17 march 2007).~Yusuf S, Hawken S, Ounpuu
  66   II,     5.  3.  2    |                  Zanetti and Primic-Zakelj, 2007)~ ~Unlike other communicable
  67   II,     5.  3.  2    |                    al, 2003; Berrino et al, 2007)~ ~· Contributing to the
  68   II,     5.  3.  2    |                   is currently absent.~ ~In 2007 the EUROCHIP Project gave
  69   II,     5.  3.  3    |                    year 2006 (Ferlay et al, 2007).~- Cancer incidence estimates
  70   II,     5.  3.  3    |            estimates in 2006 (Ferlay et al, 2007). The WHO Database provides
  71   II,     5.  3.  3    |                    al, 2003; Berrino et al, 2007; Verdecchia et al, 2007).
  72   II,     5.  3.  3    |                     2007; Verdecchia et al, 2007). In the case of Czech Republic,
  73   II,     5.  3.  4    |                    of stomach cancer (WCRF, 2007).~ ~Colorectal cancer: the
  74   II,     5.  3.  4    |                  against this cancer (WCRF, 2007). Cancer control priority
  75   II,     5.  3.  4    |            diagnosed in premenopause (WCRF, 2007).~ ~Cervical cancer: the
  76   II,     5.  3.  5    |                around Europe (Ferlay et al, 2007). Maximum incidence rates (
  77   II,     5.  3.  5    |               stomach cancer (Ferlay et al, 2007). In 2006 maximum levels
  78   II,     5.  3.  5    |                    in Europe (Ferlay et al, 2007). Figures 5.3.9 show that
  79   II,     5.  3.  5    |             estimated deaths (Ferlay et al, 2007). Worldwide, it is by far
  80   II,     5.  3.  5    |                entire Europe (Ferlay et al, 2007). The high incidence rates
  81   II,     5.  3.  5    |                 Figure 5.3.19 shows that in 2007 mortality rates varied by
  82   II,     5.  3.  5    |                    in Europe (Ferlay et al, 2007). Comparison of prostate
  83   II,     5.  3.  6    |                    1995-1999~Berrino et al (2007) analysed data from 83 cancer
  84   II,     5.  3.  6    |                 2000-2002~Verdecchia et al (2007) analysed survival data
  85   II,     5.  3.  7    |            detectable (Hakama and De Konig, 2007).~ ~Screening has been shown
  86   II,     5.  3.  7    |               cancer drugs” (Jonsson et al, 2007) highlights the inequities
  87   II,     5.  3.  7    |               community (Haward and Borras, 2007):~ ~ All populations need
  88   II,     5.  3.  7    |                    other European States in 2007~ ~ ~BELGIUM~No~BULGARIA~
  89   II,     5.  3.  7    |                Source: Haward R, Borras MJ (2007)~ ~ ~Important unexplained
  90   II,     5.  3.  7    |              minimal additional cost.~ ~The 2007 Portuguese Presidency of
  91   II,     5.  3.  7    |                European Parliament (October 2007) calls on the Council and
  92   II,     5.  3.  8    |                    outlined (Micheli et al, 2007). Moreover, the successful
  93   II,     5.  3.  9    |                     EUROCARE Working group (2007): Survival for eight major
  94   II,     5.  3.  9    |                     M, Colombet M, Boyle P (2007): Estimates of the cancer
  95   II,     5.  3.  9    |                      Hakama M, De Koning H (2007): Portuguese Presidency
  96   II,     5.  3.  9    |                     the EU (JulyDecember 2007) Health Strategies in Europe,
  97   II,     5.  3.  9    |                     in Europe, 1213 July 2007, Strategies on Specific
  98   II,     5.  3.  9    |                        Haward R, Borras MJ (2007): Portuguese Presidency
  99   II,     5.  3.  9    |                     the EU (JulyDecember 2007) Health Strategies in Europe,
 100   II,     5.  3.  9    |                     in Europe, 1213 July 2007, Strategies on Specific
 101   II,     5.  3.  9    |                       Jonsson B, Wilking N (2007): Summary. Ann Onc 18 (Suppl
 102   II,     5.  3.  9    |                  Verdecchia A, Pierotti MA (2007): Strategies for cancer
 103   II,     5.  3.  9    |                     8 (9): 784-796.~ ~WCRF (2007): Food, Nutrition, Physical activity,
 104   II,     5.  4.  1    |                 ethnic differences. (Smith, 2007; Dyhr, 2007; Diaz, 2007).
 105   II,     5.  4.  1    |            differences. (Smith, 2007; Dyhr, 2007; Diaz, 2007). Specific individual
 106   II,     5.  4.  1    |                     2007; Dyhr, 2007; Diaz, 2007). Specific individual characteristics
 107   II,     5.  4.  2    |                     Countries for the years 2007 and forecasts are given
 108   II,     5.  4.  3    |                 studied (TRIGR study group. 2007). A steady increase of the
 109   II,     5.  4.  3    |                    According to the IDF, in 2007 a total of over 300,000
 110   II,     5.  4.  6    |                   According to Waugh et al (2007), the scope for screening
 111   II,     5.  4.  6    |                recent paper (Jessani et al. 2007) investigated patients with
 112   II,     5.  4.  6    |             observed every year starting in 2007.~ ~
 113   II,     5.  4.  8    |                    of Public Health.~Dia A (2007): How does ethnicity affect
 114   II,     5.  4.  8    |                  Med. Eprint Aug 24~Dyhr J (2007): Immigrants and type 2
 115   II,     5.  4.  8    |                     10 October 2008)~Jes . (2007); Should oral glucose tolerance
 116   II,     5.  4.  8    |               Inform. 2002;90:282-7.~Smi P (2007): Economics of Health and
 117   II,     5.  4.  8    |                    104(33):13225-31~TRIG p (2007): Study design of the Trial
 118   II,     5.  4.  8    |                Diabetes 8(3):117-37~Waug A (2007): Screening for type 2 diabetes:
 119   II,     5.  4.  8    |            modelling Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi,
 120   II,     5.  5.  1    |                   two to threefold (Fryers, 2007, Blakely et al, 2003) although
 121   II,     5.  5.  1    |              indirect costs (Sobocki et al, 2007).~ ~Undertreatment and underrecognition
 122   II,     5.  5.  1    |           depression are common (Lecrubier, 2007). In Europe, only one third
 123   II,     5.  5.  1    |                    mood disorders (Kessler, 2007). Anxiety disorders are
 124   II,     5.  5.  1    |                     States (Kessler et al., 2007). The onset of anxiety symptoms
 125   II,     5.  5.  1    |                  adulthood (Kessler et al., 2007). Anxiety disorders are
 126   II,     5.  5.  1    |                  anxiety disorders (Fryers, 2007).~ ~Anxiety disorders cause
 127   II,     5.  5.  1    |                 recent year available as of 2007). Lithuania, Hungary and
 128   II,     5.  5.  1    |                   of the country (Kennelly, 2007).~ ~Non-fatal self-harm.
 129   II,     5.  5.  1    |                        Alonso J, Lépine JP (2007). Overview of key data from
 130   II,     5.  5.  1    |                   health_en.htm~ ~Fryers T (2007). Childhood determinants
 131   II,     5.  5.  1    |             Longevity Center.~ ~Kennelly B (2007). The economic cost of suicide
 132   II,     5.  5.  1    |                  Crisis 28(2):89-94.~ ~K B (2007): Lifetime prevalence and
 133   II,     5.  5.  1    |                  MHEDEA 2000 Investigators (2007). Differences in lifetime
 134   II,     5.  5.  1    |                Services 58: 213-220.~ ~L . (2007). Widespread under-recognition
 135   II,     5.  5.  1    |                     2):87-98.~ ~S F et al. (2007). The economic burden of
 136   II,     5.  5.  2    |               available) (Alzheimer Europe, 2007).~ ~
 137   II,     5.  5.  2    |                     Foundation, 2008; EPHA, 2007)~ ~In the framework of Alzheimer
 138   II,     5.  5.  2    |                     2008 (Alzheimer Europe, 2007).~ ~
 139   II,     5.  5.  2    |                   dependent relatives.~ ~In 2007, Alzheimer Europe received
 140   II,     5.  5.  2    |                EuroCoDe” (Alzheimer Europe, 2007). This led to the creation
 141   II,     5.  5.  2    |               Bundesministerium der Justiz, 2007). Switzerland, the Netherlands
 142   II,     5.  5.  2    |                    developments~ ~September 2007 saw the launch of the Paris
 143   II,     5.  5.  2    |                  Europe~ ~Alzheimer Europe (2007): EuroCoDe, WP4 survey on
 144   II,     5.  5.  2    |               Bundesministerium der Justiz (2007): better protection for
 145   II,     5.  5.  2    |                     accessed on 13 December 2007)~ ~Cooper B (2002): Thinking
 146   II,     5.  5.  2    |                     Public Health Alliance (2007): summary of a report by
 147   II,     5.  5.  2    |                     accessed on 30 November 2007)~ ~European Parliament (
 148   II,     5.  5.  3    |                   attitudes (Berkman et al, 2007). An anorectic or bulimic
 149   II,     5.  5.  3    |                    articles (Berkman et al, 2007; Hoek and van Hoeken, 2003).~ ~
 150   II,     5.  5.  3    |              sufficient yet (Berkman et al, 2007). Alexander and Rigby (in
 151   II,     5.  5.  3    |             published yet (De Henauw et al, 2007). ~ ~ ~
 152   II,     5.  5.  3    |                  WHO, 2004).~Berkman et al (2007) reviewed various surveys,
 153   II,     5.  5.  3    |                   resources (Berkman et al, 2007). Social pressure to be
 154   II,     5.  5.  3    |                  Lohr, K. N.; Bulik, C. M. (2007): Outcomes of Eating Disorders:
 155   II,     5.  5.  3    |                     the HELENA Study Group (2007): Nutritional status and
 156   II,     5.  5.  3    |                online, accessed on 12 March 2007).~The Cleveland Clinic Foundation (
 157   II,     5.  5.  3    |                online, accessed on 12 March 2007).~World Health Organization (
 158   II,     5.  5.  3    |                    et al, 1997; Saha et al, 2007).~AetiologySymptoms –
 159   II,     5.  5.  3    |                    and suicide (Saha et al, 2007). Databases on suicides
 160   II,     5.  5.  3    |                 stated in literature (Saha, 2007).~People with schizophrenia
 161   II,     5.  5.  3    |            increased over time (Saha et al, 2007). A recent epidemiological
 162   II,     5.  5.  3    |                     middle age (Fors et al, 2007).~Thus, mortality increasing
 163   II,     5.  5.  3    |                   the mortality rate (Saha, 2007).~The mortality data attributed
 164   II,     5.  5.  3    |             Statistical Committee (NOMESCO, 2007) indicate that there is
 165   II,     5.  5.  3    |                     health conditions (WHO, 2007). In terms of years lived
 166   II,     5.  5.  3    |              research and practice (Priebe, 2007). The importance of social
 167   II,     5.  5.  3    |                   population (Leucht et al, 2007).~Available statistics do
 168   II,     5.  5.  3    |               pathomechanism (Prince et al, 2007). In addition, people affected
 169   II,     5.  5.  3    |                    Pitschel-Walz and Bäuml, 2007) demonstrated beneficial
 170   II,     5.  5.  3    |                    al, 2005; Klosterkötter, 2007).~The gap between need and
 171   II,     5.  5.  3    |                sociotherapy (Pitschel-Walz, 2007; Vauth, 2006,; Glynn, 2003;
 172   II,     5.  5.  3    |                    drug class (Knapp et al, 2007). According to NOMESCO figures,
 173   II,     5.  5.  3    |                     atypicals (Knapp et al, 2007) (Figure 5.5.3.3.5).~Figure
 174   II,     5.  5.  3    |                 consequences (Byerly et al, 2007). A substantial proportion
 175   II,     5.  5.  3    |                     in Italy (Buizza et al, 2007) evaluated four dimensions
 176   II,     5.  5.  3    |                    contacts (Lysaker et al, 2007) – factors associated with
 177   II,     5.  5.  3    |               provision of care (Sartorius, 2007). Stigma marks those who
 178   II,     5.  5.  3    |               mentally ill (Fang and Rizzo, 2007).~Schizophrenia especially
 179   II,     5.  5.  3    |                   diagnosis (Baumann et al, 2007).~As stated in the EU Green
 180   II,     5.  5.  3    |                     years (Lindström et al, 2007)~Table 5.5.3.2.6. Expenditures
 181   II,     5.  5.  3    |                   EU strategy (Knapp et al, 2007).~Database~Since strategies
 182   II,     5.  5.  3    |                    symptoms (Klosterkötter, 2007). Respective programmes –
 183   II,     5.  5.  3    |                     W, Möller HJ, Gaebel W (2007): Changes in the public'
 184   II,     5.  5.  3    |                     G, Ghilardi A, Pioli R (2007): The stigma of schizophrenia
 185   II,     5.  5.  3    |                Nakonezny PA, Lescouflair E (2007): Antipsychotic medication
 186   II,     5.  5.  3    |                  pdf; last accessed Dec 13, 2007.~European Commission (2006):
 187   II,     5.  5.  3    |                  htm; last accessed Dec 13, 2007.~European Commission (2006a):
 188   II,     5.  5.  3    |                    eds.).~Fang H, Rizzo JA (2007): Do psychiatrists have
 189   II,     5.  5.  3    |                    Bingefors K, Widerlöv B (2007): Mortality among persons
 190   II,     5.  5.  3    |                    W, Decker P, Möller HJ. (2007): Evaluation of the German
 191   II,     5.  5.  3    |               interventions. Schizophr Res. 2007 Oct 23 [Epub ahead of print].~
 192   II,     5.  5.  3    |                 1085-1097.~Klosterkötter J (2007): Prevention in Psychiatry: “
 193   II,     5.  5.  3    |                 Mossialos E, Thornicroft G (2007): Mental Health Policy and
 194   II,     5.  5.  3    |            Henderson J, Maj M, Sartorius N (2007): Physical illness and schizophrenia:
 195   II,     5.  5.  3    |                      Neovius M, Levander S (2007): Costs of schizophrenia
 196   II,     5.  5.  3    |                     Tsai J, Yanos P, Roe D (2007): Associations of multiple
 197   II,     5.  5.  3    |                   Pitschel-Walz G, Bäuml J (2007): Psychotherapie bei Schizophrenien –
 198   II,     5.  5.  3    |                    34(1):S28-S32.~Priebe S (2007): Social outcomes in schizophrenia.
 199   II,     5.  5.  3    |                      Phillips MR, Rahman A (2007): No health without mental
 200   II,     5.  5.  3    |                     S, Chant D, McGrrath J (2007): A systematic review of
 201   II,     5.  5.  3    |                   10):1123-31.~Sartorius N (2007): Stigma and mental health.
 202   II,     5.  5.  3    |                      Section B, p. 257-333, 2007.~htt df~Vauth R (2006):
 203   II,     5.  5.  3    |                       last accessed Dec 13, 2007.~World Health Organization (
 204   II,     5.  5.  3    |                       last accessed Dec 13, 2007.~World Health Organisation (
 205   II,     5.  5.  3    |                       last accessed Dec 13, 2007.~World Health Organization (
 206   II,     5.  5.  3    |                       last accessed Dec 13, 2007.~World Health Organization (
 207   II,     5.  5.  3    |                       last accessed Dec 13, 2007.~World Health Organization (
 208   II,     5.  5.  3    |                       last accessed Dec 14, 2007.~Wrigley S, Jackson H, Judd
 209   II,     5.  5.  3    |            disability (Sanchéz-Valle et al, 2007).~ ~ ~ ~
 210   II,     5.  5.  3    |                     partners, (Knapp et al, 2007). The findings reveal that
 211   II,     5.  5.  3    |                Knapp M, Romeo R, Beecham J (2007): The economic consequences
 212   II,     5.  5.  3    |                      Sánchez-Valle E et al (2007): Estimating the Burden
 213   II,     5.  5.  3    |                   population (Smeets et al, 2007). However, most studies
 214   II,     5.  5.  3    |                 unemployment (Smeets et al, 2007). Psychosocial factors also
 215   II,     5.  5.  3    |            virtually unknown (Smeets et al, 2007).~ ~Epilepsy and driving~
 216   II,     5.  5.  3    |                      Vanhoutvin JPG, et al (2007): Epilepsy and employment:
 217   II,     5.  5.  3    |                 Myhr et al, 2006; www ). In 2007, a biobank unit for collection
 218   II,     5.  5.  3    |                centers (Flachenecker et al, 2007).~ ~ ~
 219   II,     5.  5.  3    |                     100 000 (Vukusic et al, 2007), and a northeast-to-southwest
 220   II,     5.  5.  3    |                     studies (Vukusic et al, 2007). Further studies showed
 221   II,     5.  5.  3    |                   countries (Sobocki et al, 2007). Costs, retrospectively
 222   II,     5.  5.  3    |                    analysis (Sobocki et al, 2007) revealed the positive psychological
 223   II,     5.  5.  3    |                  updated and edited version 2007 (MSTCG, 2007) of the original
 224   II,     5.  5.  3    |                 edited version 2007 (MSTCG, 2007) of the original report
 225   II,     5.  5.  3    |            conference hosted by EMSP in May 2007, it was conveyed that developments
 226   II,     5.  5.  3    |                  Zettl UK, Elias WG, et al (2007): MS Register in Germany –
 227   II,     5.  5.  3    |                      Czech Republic October 2007.~Forbes RB, Wilson SV, Swingler
 228   II,     5.  5.  3    |                   therapy consensus group) (2007): “Escalating Immunomodulatory
 229   II,     5.  5.  3    |                     Paper , Revised version 2007~Murray CJL, Lopez AD (2000):
 230   II,     5.  5.  3    |             Pugliatti M, Lauer L, Kobelt G (2007): Estimation of the cost
 231   II,     5.  5.  3    |                   Gosselin S, Confavreux C (2007): Regional variations in
 232   II,     5.  5.  3    |                 Nath et al, 2005; Orphanet, 2007; Vanacore, 2005).~Although,
 233   II,     5.  5.  3    |                    Bundesamt für Statistik, 2007; EUROSTAT, 2002). Several
 234   II,     5.  5.  3    |                    al, 2005; McCrone et al, 2007; Spottke et al, 2005). Direct
 235   II,     5.  5.  3    |             Schöffski and v.d. Schulenburg, 2007).~ ~PD, employment and indirect
 236   II,     5.  5.  3    |                   disorders is low (Gasser, 2007). Environmental causes have
 237   II,     5.  5.  3    |               disease (Elbaz and Tranchant, 2007; Quik, 2004; Chade et al
 238   II,     5.  5.  3    |                    3 million (Dorsey et al, 2007). The burden of PD will
 239   II,     5.  5.  3    |                    Bundesamt für Statistik (2007): ht /.~Bundesministerium
 240   II,     5.  5.  3    |                      Siderowf A, Tanner CM (2007): Projected number of people
 241   II,     5.  5.  3    |                  128.~Elbaz A, Tranchant C (2007): Epidemiologic studies
 242   II,     5.  5.  3    |                    10):1139-1145.~Gasser T (2007): Update on the genetics
 243   II,     5.  5.  3    |                     P, Allcock LM, Burn DJ (2007): Predicting the cost of
 244   II,     5.  5.  3    |               Disord 10(1):19-21.~Orphanet (2007): Prävalenzen seltener Krankheiten:
 245   II,     5.  5.  3    |                      v.d. Schulenburg J-M., 2007. Gesundheitsökonomische
 246   II,     5.  6.  1    |                     Special Report No 272e, 2007). They are a major burden
 247   II,     5.  6.  3    |                     Special Report No 272e, 2007). A survey in Norway found
 248   II,     5.  6.  3    |                     Special Report No 272e, 2007).~ ~The prevalence of physical
 249   II,     5.  6.  3    |                    the knee and hip (Woolf, 2007). One study showed obesity
 250   II,     5.  6.  3    |             antibodies marker (Combe et al, 2007).~ ~Natural history~ ~Inflammatory
 251   II,     5.  6.  3    |            manifestations (Naz and Symmons, 2007). Co-morbidity, especially
 252   II,     5.  6.  4    |        Eurobarometer Special Report No 283, 2007).~ ~The associated health
 253   II,     5.  6.  6    |               Silman A, Smolen J, Yazici H (2007): EULAR Recommendations
 254   II,     5.  6.  6    |                        European Commission (2007): Health in the European
 255   II,     5.  6.  6    |                   28~Naz SM and Symmons DP (2007): Mortality in Established
 256   II,     5.  6.  6    |                Rheum Dis 59:81-82~Woolf AD (2007): What healthcare services
 257   II,     5.  7.  1    |                     2006; Van Biesen et al, 2007); these studies indicate
 258   II,     5.  7.  1    |               population (Pontoriero et al, 2007). Renal transplantation
 259   II,     5.  7.  2    |                 Barcelona, 21st - 24th June 2007) (Zoccali and DeJong, 2007)
 260   II,     5.  7.  2    |                  2007) (Zoccali and DeJong, 2007) and unpublished information
 261   II,     5.  7.  3    |                   Renal Data System, USRDS, 2007) are 1.5-3 times as high
 262   II,     5.  7.  3    |                patients (Jager and van Dijk 2007) resulted in a concomitant
 263   II,     5.  7.  3    |                 limited (Warady and Chadha, 2007; Ardissino et al 2003).
 264   II,     5.  7.  3    |                    Garcia-Lopez and Epirce, 2007) is shown in Figure 5.7.
 265   II,     5.  7.  3    |                   databases (Stevens et al, 2007). Stage 3-5 CKD prevalence
 266   II,     5.  7.  3    |                  Belgium (Van Biesen et al, 2007) , England (Stevens et al,
 267   II,     5.  7.  3    |                     England (Stevens et al, 2007), Iceland (Viktorsdottir
 268   II,     5.  7.  3    |                   Renal Data System, USRDS ,2007).~ ~Table 5.7.6A. Prevalence
 269   II,     5.  7.  3    |                   2006; Zoccali and DeJong, 2007), while the prevalence of
 270   II,     5.  7.  3    |                  with decreasing GFR (USRDS 2007 ). Mortality in ESRD patients
 271   II,     5.  7.  3    |                    2003; Warady and Chadha, 2007; ERA-EDTA Registry, 2005).
 272   II,     5.  7.  3    |                   survival (van Dijk et al, 2007). International studies
 273   II,     5.  7.  3    |                patients (Jager and van Dijk 2007) resulted in a concomitant
 274   II,     5.  7.  4    |                     diabetes (Loucks et al, 2007; Seligman et al, 2007) in
 275   II,     5.  7.  4    |                   al, 2007; Seligman et al, 2007) in adults and obesity in
 276   II,     5.  7.  4    |            population) (Jager and van Dijk, 2007). Another factor that must
 277   II,     5.  7.  5    |                   two years.~· In Poland in 2007 a programme to detect CKD
 278   II,     5.  7.  5    |                     mellitus.~· Since April 2007 German dialysis centres,
 279   II,     5.  7.  5    |              progress.~· In Italy, in March 2007, a report by the Istituto
 280   II,     5.  7.  5    |                 diseases. On September 26th 2007, after a special convention
 281   II,     5.  7.  5    |                     the year up to to March 2007,the first in which this
 282   II,     5.  7.  5    |             NephroQUEST (Jager and Zoccali, 2007) is an initiative promoted
 283   II,     5.  7.  6    |              initiative (Jager and Zoccali, 2007). This initiative includes
 284   II,     5.  7.  7    |            Amsterdam, The Netherlands, June 2007.~Esbjorner E, Berg U, Hansson
 285   II,     5.  7.  7    |                    Renal Cronica en Espana (2007): XLIV ERA-EDTA pre-songress
 286   II,     5.  7.  7    |                meeting, Barcelona 21st June 2007.~Go AS, Chertow GM, Fan
 287   II,     5.  7.  7    |                      Jager KJ, van Dijk PC (2007): Has the rise in the incidence
 288   II,     5.  7.  7    |                     Nephrol Dial Transplant 2007;22:678-80.~Jager KJ, Zoccali
 289   II,     5.  7.  7    |                    80.~Jager KJ, Zoccali C (2007): Clinical databases and
 290   II,     5.  7.  7    |                     initiative. Blood Purif 2007;25(3):219-20.~Kimmel PL,
 291   II,     5.  7.  7    |                     Thurston RC, Kawachi I (2007): Socioeconomic disparities
 292   II,     5.  7.  7    |                   NHANES III. Ann Epidemiol 2007 Jan;17(1):19-26.~Lysaght
 293   II,     5.  7.  7    |                    Vecchio LD, Locatelli F (2007): International Study of
 294   II,     5.  7.  7    |                    Health Care Finance Econ 2007 Jul 20.~Rodgers A, Ezzati
 295   II,     5.  7.  7    |                    E, Kanaya AM, Kushel MB (2007): Food insecurity is associated
 296   II,     5.  7.  7    |                 1999-2002. J Gen Intern Med 2007 Jul;22(7):1018-23.~Smith
 297   II,     5.  7.  7    |                Klebe B, Middleton R, et al (2007): Chronic kidney disease
 298   II,     5.  7.  7    |                 project results. Kidney Int 2007 Jul;72(1):92-9.~Stewart
 299   II,     5.  8.  1    |                   years (Mannino and Buist, 2007). Moreover, significant
 300   II,     5.  8.  3    |                       Boutin-Forzano et al, 2007).~ ~The IBERPOC study, carried
 301   II,     5.  8.  3    |                     for women (Buist et al, 2007). In Salzburg (Austria),
 302   II,     5.  8.  3    |            participants (Schirnhofer et al, 2007).~ ~The Obstructive Lung
 303   II,     5.  8.  3    |                   study, Gudmundsson et al (2007) performed an analysis of
 304   II,     5.  8.  3    |                    by Boutin-Forzano et al (2007), different co-morbidities
 305   II,     5.  8.  3    |                osteopenia (Jorgensen et al, 2007). This increased prevalence
 306   II,     5.  8.  3    |                  Recently, Fabbri and Rabe (2007) proposed the additional
 307   II,     5.  8.  3    |             treatment of COPD (Bilde et al, 2007). The net cost for COPD
 308   II,     5.  8.  3    |                    than for asthma (Vrbica, 2007)..~ ~
 309   II,     5.  8.  4    |                    of intervention (Mannino 2007).~ ~
 310   II,     5.  8.  5    |                  awareness (Bousquet et al, 2007).~ ~Another important initiative
 311   II,     5.  8.  5    |                     diseases (MacNee et al, 2007).~ ~
 312   II,     5.  8.  7    |                Baekke Borgeskov H, Lange P (2007): The cost of treating patients
 313   II,     5.  8.  7    |               non-COPD controls. Respir Med 2007; 101: 539-546.~ ~B N (2007):
 314   II,     5.  8.  7    |                  2007; 101: 539-546.~ ~B N (2007): Global Alliance against
 315   II,     5.  8.  7    |          Respiratory Diseases.~Eur Respir J 2007; 29: 233-239.~ ~Boutin-Forzano
 316   II,     5.  8.  7    |               Charpin D, Annesi-Maesano I. (2007) : Reported prevalence and
 317   II,     5.  8.  7    |           estimation. Int J Tuberc Lung Dis 2007; 11: 695-702.~ ~Buist AS,
 318   II,     5.  8.  7    |               pagine)~ ~Fabbri LM, Rabe KF (2007): From COPD to chronic systemic
 319   II,     5.  8.  7    |              inflammatory syndrome?. Lancet 2007; 370: 797-799.~ ~Fabbri
 320   II,     5.  8.  7    |           publication, accessed on 16 April 2007)~ ~Gorecka D, Bednarek M,
 321   II,     5.  8.  7    |                  Aine T, Bakke P, Janson C (2007): Mortality in COPD patients
 322   II,     5.  8.  7    |                      Petersen LJ, Backer V (2007): The prevalence of osteoporosis
 323   II,     5.  8.  7    |                 sectional study. Respir Med 2007; 101: 177-185.~ ~Kriegsman
 324   II,     5.  8.  7    |                 MacNee W, Viegi G, Kamel N (2007): New opportunities for
 325   II,     5.  8.  7    |                   Europe: FP7. Eur Respir J 2007; 29: 223-225.~ ~Mannino
 326   II,     5.  8.  7    |                       Mannino DM, Buist AS (2007): Global burden of COPD:
 327   II,     5.  8.  7    |                     M, Jensen RL, Buist AS (2007): COPD prevalence in Salzburg,
 328   II,     5.  8.  7    |                 Disease (BOLD) Study. Chest 2007; 131: 29-36.~ ~Siafakas
 329   II,     5.  8.  7    |                      126; 1093-1101.~ ~V . (2007): Definition, epidemiology
 330   II,     5.  8.  7    |               history of COPD. Eur Respir J 2007; 30: 993–1013~ ~Vrbica  (
 331   II,     5.  8.  7    |                    30: 993–1013~ ~Vrbica  (2007): COPD and Asthma: comparison
 332   II,     5.  9. FB    |                  under debate (Plumb et al, 2007; Story, 2007)~There are
 333   II,     5.  9. FB    |                   Plumb et al, 2007; Story, 2007)~There are contrasting data
 334   II,     5.  9. FB    |                     ys of age (Bener et al, 2007). On the contrary, the Avon
 335   II,     5.  9. FB    |                     J, Brawer R, Brisbon N (2007): The interplay of obesity
 336   II,     5.  9. FB    |                  allergy and asthma reports 2007, 7:385-389.~ ~Story RE (
 337   II,     5.  9. FB    |                      7:385-389.~ ~Story RE (2007): Asthma and obesity in
 338   II,     5.  9.  1    |                 asthma alone (Braido et al, 2007). Therefore, an optimal
 339   II,     5.  9.  2    |                    survey (Compalati et al, 2007) has analyzed the results
 340   II,     5.  9.  2    |                    ISAAC) (Björkstén et al, 2007) and the second one was
 341   II,     5.  9.  3    |                  survey by Compalati et al, 2007 reported that the highest
 342   II,     5.  9.  3    |                   The AllergyNet of the May 2007 issue of Allergy (Mantovani
 343   II,     5.  9.  3    |                   Allergy (Mantovani et al, 2007), reported that in 2003
 344   II,     5.  9.  3    |                    was 750.18 Euro (Vrbica, 2007). It was found that all
 345   II,     5.  9.  4    |                    implicated (Osman et al, 2007).~ These findings have been
 346   II,     5.  9.  4    |           prevalence by only 1% ( Bousquet, 2007) The same study showed a
 347   II,     5.  9.  4    |                   most prevalent (Bousquet, 2007)~ ~Prevalence of both atopic
 348   II,     5.  9.  4    |                 North of Italy (Duse et al, 2007). A modified version of
 349   II,     5.  9.  4    |           Adolescents (KiGGS) (Sc ud et al, 2007), for instance, information
 350   II,     5.  9.  4    |                     study, (Migliore et al, 2007) performed in 12 I Italian
 351   II,     5.  9.  7    |                     Apr;9(4):636-42~ ~Bj P (2007): Worldwide time trends
 352   II,     5.  9.  7    |                    Pediatr Allergy Immunol. 2007 Jul 25; [Epub ahead of print]~ ~B I (
 353   II,     5.  9.  7    |                      Baiardini I, Brandi S (2007): Allergic rhinitis and
 354   II,     5.  9.  7    |                      Henley K, Canonica GW (2007): Allergy prevalence survey
 355   II,     5.  9.  7    |                     110(2):228-35~ ~Duse M (2007): High prevalence of atopy,
 356   II,     5.  9.  7    |                    Pediatr Allergy Immunol. 2007 May;18(3):201-8~ ~Erwin
 357   II,     5.  9.  7    |                 Canonica GW, Passalacqua G (2007): Allergic rhinitis in the
 358   II,     5.  9.  7    |                    5):569-71)~ ~Migliore E (2007): Prevalence of respiratory
 359   II,     5.  9.  7    |                     SIDRIA-2 study. Allergy 2007; 62:293-300~ ~Osman M (2007):
 360   II,     5.  9.  7    |                 2007; 62:293-300~ ~Osman M (2007): Changing trends in sex
 361   II,     5.  9.  7    |                  Press, 1990: 11-23~ ~Sc W (2007): Allergic diseases. Results
 362   II,     5.  9.  7    |                   study. An Pediatr (Barc). 2007 Feb;66(2):154-8~ ~The UCB
 363   II,     5.  9.  7    |                 2006;61:407-413~ ~Vrbica  (2007): COPD and Asthma: comparison
 364   II,     5.  9.  7    |                    Journal of Public Health 2007; 3(10) - www.hcjz.hr~ ~Wang
 365   II,     5. 10.  1    |               quality of life (Mills et al, 2007). On the one hand, adequate
 366   II,     5. 10.  2    |                diagnosis of FA (Rona et al, 2007). For the purpose of this
 367   II,     5. 10.  3    |                  was about 12% (Rona et al, 2007).~ ~Figure 5.10.2. Reported
 368   II,     5. 10.  5    |                  products thereof~Directive 2007/68/EC~Exempted from labelling:~ ~(
 369   II,     5. 10.  5    |                   granted until 25 November 2007. Requests for exemptions
 370   II,     5. 10.  5    |                  recently adopted Directive 2007/68/EC (EC, 2007) establishing
 371   II,     5. 10.  5    |                   Directive 2007/68/EC (EC, 2007) establishing a list of
 372   II,     5. 10.  6    |               urgently needed (Asero et al, 2007).~ ~Furthermore, any efforts
 373   II,     5. 10.  6    |                 individuals (de Blok et al, 2007), but it takes as well a
 374   II,     5. 10.  6    |                 Taylor, 2006; Thomas et al, 2007).~ ~
 375   II,     5. 10.  7    |                   Clare Mills EN, Vieths S (2007): IgE-Mediated food allergy
 376   II,     5. 10.  7    |                     L, Mills C, AEJ Dubois (2007): A framework for measuring
 377   II,     5. 10.  7    |                        European Commission (2007): Commission Directive 2007/
 378   II,     5. 10.  7    |                 2007): Commission Directive 2007/68/EC of 27 November 2007
 379   II,     5. 10.  7    |                   2007/68/EC of 27 November 2007 amending Annex IIIa to Directive
 380   II,     5. 10.  7    |                 European Union L 310, 28.11.2007, pp. 1114.~ ~European Food
 381   II,     5. 10.  7    |                      Crevel RWR, van Ree R (2007): The prevalence, cost and
 382   II,     5. 10.  7    |                    Goldhahn K, Dahlstrom J (2007): The prevalence of food
 383   II,     5. 10.  7    |                    C, Privalle L, Vieths S (2007): Evaluating the effect
 384   II,     5. 10.  7    |                  report. Food Chem Toxicol. 2007 Jul;45(7):1116-22. Epub
 385   II,     5. 10.  7    |                     Jul;45(7):1116-22. Epub 2007 Jan 9.~ ~Woods RK, Abramson
 386   II,     5. 11.  3    |                   standards (B Bocca et al, 2007). Similarly, in Finland,
 387   II,     5. 11.  3    |                   of the Total Environment, 2007;388:24-34.~L Dotterud, E
 388   II,     5. 11.  3    |                       Gudjonsson and Elder, 2007).~ ~Acne~Acne is so common
 389   II,     5. 11.  7    |                    Gudjonsson JE, Elder JT (2007): Psoriasis: epidemiology.
 390   II,     5. 11.  7    |                 epidemiology. Clin Dermatol 2007;25:535-546.~ ~Hay R (2005):
 391   II,     5. 11.  7    |                 clinical excellence (NICE) (2007): clinical guideline 57 –
 392   II,     5. 11.  7    |                 eczema in children, London: 2007.~ ~Nielsen NH, Mennè T (
 393   II,     5. 12.  1    |                    al, 2000; Bosetti et al, 2007). The patterns in mortality
 394   II,     5. 12.  2    |                     countries as to January 2007. For Belgium, data were
 395   II,     5. 12.  7    |                      Negri E, La Vecchia C (2007): Worldwide mortality from
 396   II,     5. 14.  1    |               lifetime (Selwitz and Ismail, 2007). To avoid pain and discomfort,
 397   II,     5. 14.  6    |                     which took place in May 2007, Member States of the World
 398   II,     5. 14.  6    |                  plan for oral health (WHO, 2007). The adoption of this action
 399   II,     5. 14.  8    |                    RH, Ismail AI, Pitts NB (2007): Dental caries. Lancet
 400   II,     5. 14.  8    |                       Dental caries. Lancet 2007; 369: 5159.~Wid A (2004):
 401   II,     5. 14.  8    |                  Health Organization (WHO) (2007): Resolution WHA60.17Oral
 402   II,     5. 15.  2    |               published articles (McKusick, 2007). OMIM lists 5,760 genetic
 403   II,     5. 15.  2    |                   Disorders (NORD database, 2007). The number of RD for which
 404   II,     5. 15.  3    |                    in 2001 (Drummond et al, 2007) on request by the French
 405   II,     5. 15.  3    |                  therapies (Drummond et al, 2007; Dear et al, 2006; Kesselman
 406   II,     5. 15.  4    |                    years.~ ~Regulation 1394/2007 of the European Parliament
 407   II,     5. 15.  4    |              products (European Commission, 2007), amending Directive 2001/
 408   II,     5. 15.  4    |                  first reading) on 31st May 2007, is also directly linked
 409   II,     5. 15.  6    |                Kanavos P, Ubel P, Rovira J (2007): Assessing the economic
 410   II,     5. 15.  6    |                 Technol Assess Health Care. 2007 Winter;23(1):36-42~European
 411   II,     5. 15.  6    |                   at: htt , (accessed 12.05.2007).~ ~European Commission (
 412   II,     5. 15.  6    |                        European Commission (2007): Regulation (EC) No 1394/
 413   II,     5. 15.  6    |                     Regulation (EC) No 1394/2007 of the European Parliament
 414   II,     5. 15.  6    |                  the Council of 13 November 2007 on advanced therapy medicinal
 415   II,     5. 15.  6    |                   At:~htt m (accessed 12.05.2007)~Eurordis (2005): Rare diseases:
 416   II,     5. 15.  6    |                   at:~htt 8 (accessed 12.05.2007)~Haffner ME (2006): Adopting
 417   II,     5. 15.  6    |                  7523):1016-9.~McKusick VA (2007): Mendelian Inheritance
 418   II,     5. 15.  6    |                     Hum Genet, 80: 588-604, 2007~NORD database of rare diseases.
 419   II,     5. 15.  6    |                   at: htt l (accessed 08.05.2007)~Orphanet database of rare diseases
 420   II,     5. 15.  6    |                   at: htt m (accessed 15.05.2007)~Wastfelt M, Fadeel B, Henter
 421   II,     6.  3.  3    |                  per million.~Source: ECDC, 2007~ ~ ~ ~ ~The epidemic in
 422   II,     6.  3.  4    |                    With the EU expansion in 2007, Romania will be the country
 423   II,     6.  4.  2    |                     the EWRS. Starting from 2007, the Centre has also been
 424   II,     7.  1        |                leading cause of death (KfV, 2007). There are large differences
 425   II,     7.  1        |                     WHO European Region. In 2007, the European Council released
 426   II,     7.  3        |              summary 20032005” (see KfV, 2007)1. See also the executive
 427   II,     7.  3.  3    |                   of injuries (Bauer et al, 2007).~ ~
 428   II,     7.  4        |                   Council Recommendation of 2007 calls upon Member States
 429   II,     7.  4.  1    |                 safety (MacKay & Vincenten, 2007); it has also issued a “
 430   II,     7.  4.  1    |            Accidents and Injury Prevention, 2007).~ ~Link to the project:~www ~ ~
 431   II,     7.  5        |                injuries and violence” (WHO, 2007; Racioppi et al, 2004).
 432   II,     7.  5        |             promotion of safety” on May 31, 2007 (Council of the European
 433   II,     7.  5        |              Council of the European Union, 2007).~ ~According to this Recommendation,
 434   II,     7.  5        |                   the European Union” (KfV, 2007).~ ~Also policy tools regarding “
 435   II,     7.  7        |                     R, Nossek G, Steiner M (2007): Freizeitunfallstatistik
 436   II,     7.  7        |              Council of the European Union (2007): Council Recommendation
 437   II,     7.  7        |               Journal of the European Union 2007/C164/1 of July 18, 2007 (
 438   II,     7.  7        |                     2007/C164/1 of July 18, 2007 (CELEX-Nr. 32007H0718).~ ~
 439   II,     7.  7        |                   Verkehrssicherheit (KfV) (2007): Injuries in the European
 440   II,     7.  7        |                   MacKay M and Vincenten J (2007): Child Safety Summary Report
 441   II,     7.  7        |                  Health Organization (WHO) (2007): Preventing injuries and
 442   II,     8.  1.  1    |                    context (Schalock et al, 2007). Within this framework,
 443   II,     8.  1.  2    |        comprehensive report (APPLICA et al, 2007). Where they cover the same
 444   II,     8.  1.  4    |                     module has been held in 2007 in Dublin at a European
 445   II,     8.  1.  5    |                    of the Action Plan (2006-2007)6 focused on the active
 446   II,     8.  1.  6    |                       CESEP & ALPHAMETRICS (2007): Men and women with disabilities
 447   II,     8.  2.  1    |                countries of the world (WHO, 2007).~People with intellectual
 448   II,     8.  2.  1    |         Schrojenstein Lantman-de Valk et al 2007).~Further, people with intellectual
 449   II,     8.  2.  1    |                  the European Union. In May 2007, an examination of a sample
 450   II,     8.  2.  1    |                Interim Reports for 2006 and 2007 that can be found on the
 451   II,     8.  2.  1    |                  approach (Schalock et al., 2007), emphasizing deficits in
 452   II,     8.  2.  1    |               interaction (Schalock et al., 2007).~ ~
 453   II,     8.  2.  1    |        Schrojenstein Lantman-de Valk et al (2007) presented evidence that
 454   II,     8.  2.  1    |                  Project: Submitted 30 June 2007).~
 455   II,     8.  2.  1    |                       Walsh, P.N., et al., (2007). POMONA Interim Report. htt df
 456   II,     8.  2.  1    |                      M.L. and Yeager, M.H. (2007). The Renaming of Mental
 457   II,     8.  2.  1    |                    Schellevis, G.J. Dinant (2007). Health problems of people
 458   II,     8.  2.  1    |               Linehan C, Kerr MP, Walsh PN (2007): Developing health indicators
 459   II,     8.  2.  1    |                  World Health Organisation (2007). Atlas - Global Resources
 460   II,     8.  2.  2    |                    in a Report published in 2007 (APPLICA et al, 2007).~ ~
 461   II,     8.  2.  2    |                     in 2007 (APPLICA et al, 2007).~ ~Definitions~ ~Visual
 462   II,     8.  2.  2    |         implementation of VISION 2020 (WHO, 2007).~The three core approaches
 463   II,     8.  2.  2    |                Living Conditions (EU-SILC) (2007): Men and women with disabilities
 464   II,     8.  2.  2    |                 Document WHO/PBL/03.91~WHO (2007): Global initiative for
 465   II,     8.  2.  3    |                    in a Report published in 2007 (APPLICA et al, 2007).~ ~
 466   II,     8.  2.  3    |                     in 2007 (APPLICA et al, 2007).~ ~Definitions~ ~There
 467   II,     8.  2.  3    |                Living Conditions (EU-SILC) (2007): Men and women with disabilities
 468   II,     9            |                 with a higher risk (Waller, 2007; EUROCAT, 2004). In the
 469   II,     9            |                    European Healthy Ageing, 2007).~ ~Smoking. The acceleration
 470   II,     9            |                    European Healthy Ageing, 2007).~ ~Lack of physical activity.
 471   II,     9            |                    European Healthy Ageing, 2007).~ ~Risk factors for falls
 472   II,     9.  1.  1    |                   countries that acceded in 2007 (Bulgaria and Romania).~ ~ ~ ~
 473   II,     9.  1.  1    |                   countries that acceded in 2007, however, was higher at
 474   II,     9.  1.  1    |                    al, 2000a; Marret et al, 2007). The preterm birth rate
 475   II,     9.  1.  1    |                    1000-1499g (Platt et al, 2007).~ ~Table 9.1.1.6. CP rates
 476   II,     9.  1.  1    |                    maternal age. Hum Reprod 2007;22(5):1264-72.~Luke B, Brown
 477   II,     9.  1.  1    |                    plurality. Fertil Steril 2007;88(2):283-93.~Magee BD (
 478   II,     9.  1.  1    |                 Topp M, Torrioli MG, et al (2007): Trends in cerebral palsy
 479   II,     9.  1.  1    |                    a database study. Lancet 2007;369(9555):43-50.~Prysak
 480   II,     9.  1.  1    |                Petrou S, Agostino R, et al (2007): Characteristics of neonatal
 481   II,     9.  1.  1    |                    MOSAIC study. Pediatrics 2007;120(4):e815-25.~ ~van Roosmalen
 482   II,     9.  1.  1    |                      Alexander S, Breart G (2007): Variation in rates of
 483   II,     9.  1.  1    |                   reality or artefact? Bjog 2007;114(9):1097-103.~ ~Zeitlin
 484   II,     9.  1.  2    |                   well as the Ukraine since 2007. The only EU countries with
 485   II,     9.  1.  2    |                    on its website (EUROCAT, 2007). Those with a total prevalence
 486   II,     9.  1.  2    |            hypoplastic left heart (EUROCAT, 2007). TOPFA is not common for
 487   II,     9.  1.  2    |                     for 2000-2004 (EUROCAT, 2007), while rates of 0.6 per
 488   II,     9.  1.  2    |                     in Europe (Loane et al, 2007) and elsewhere in the world.
 489   II,     9.  1.  2    |                     pregnancy (Loane et al, 2007). In Italy however, rates
 490   II,     9.  1.  2    |                   experienced (Loane et al, 2007). The great majority of
 491   II,     9.  1.  2    |              prenatally diagnosed (EUROCAT, 2007), but TOPFA is rare as the
 492   II,     9.  1.  2    |                 with a higher risk (Waller, 2007; EUROCAT, 2004). In the
 493   II,     9.  1.  2    |                      2005b; Abramsky et al, 2007; EUROCAT, 2005) and is the
 494   II,     9.  1.  2    |                   and de Jong van den Berg, 2007). Some European countries
 495   II,     9.  1.  2    |                     defects (De Wals et al, 2007). For example, this has
 496   II,     9.  1.  2    |                   is prenatal (Garne et al, 2007). This is a potentially
 497   II,     9.  1.  2    |                   Folic Acid Working Group (2007): "Should Europe Fortify
 498   II,     9.  1.  2    |                    de Jong van den Berg LT (2007): Growing gap in folic acid
 499   II,     9.  1.  2    |             Netherlands. Community Genetics 2007; 10:93-6.~De Wals P et al, (
 500   II,     9.  1.  2    |                     93-6.~De Wals P et al, (2007): Reduction in neural tube